Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-11
2011-01-11
Solola, Taofiq A (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S459000
Reexamination Certificate
active
07868041
ABSTRACT:
The present invention provides cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, methods of making cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs and compositions of cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs. The present invention also provides methods of using cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs and compositions of cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs.
REFERENCES:
patent: 4024175 (1977-05-01), Satzinger et al.
patent: 5563175 (1996-10-01), Silverman et al.
patent: 6020370 (2000-02-01), Horwell et al.
patent: 6028214 (2000-02-01), Silverman et al.
patent: 6054482 (2000-04-01), Augart et al.
patent: 6103932 (2000-08-01), Horwell et al.
patent: 6117906 (2000-09-01), Silverman et al.
patent: 7026351 (2006-04-01), Gallop et al.
patent: WO 92/09560 (1992-06-01), None
patent: WO 93/23383 (1993-11-01), None
patent: WO 97/29101 (1997-08-01), None
patent: WO 97/33858 (1997-09-01), None
patent: WO 97/33859 (1997-09-01), None
patent: WO 98/17627 (1998-04-01), None
patent: WO 99/08671 (1999-02-01), None
patent: WO 99/21824 (1999-05-01), None
patent: WO 99/31057 (1999-06-01), None
patent: WO 99/31074 (1999-06-01), None
patent: WO 99/31075 (1999-06-01), None
patent: WO 99/61424 (1999-12-01), None
patent: WO 00/15611 (2000-03-01), None
patent: WO 00/31020 (2000-06-01), None
patent: WO 00/50027 (2000-08-01), None
patent: WO 01/80830 (2001-11-01), None
patent: WO 02/00209 (2002-01-01), None
Bryans et al., 3-Substituted GABA analogs with central nervous system activity: a review.Med Res Rev1999, 19(2), 149-77.
Jezyk et al., Transport of pregabalin in rat intestine and Caco-2 monolayers.Pharm Res1999, 16(4), 519-26.
Magnus, Nonepileptic uses of gabapentin.Epilepsia1999, 40 Suppl 6, S66-S72.
Verma et al., Osmotically controlled oral drug delivery.Drug Dev Ind Pharm2000, 26(7), 695-708.
International Search Report dated Jul. 8, 2003, and International Preliminary Examination Report dated Aug. 3, 2004, of the International Searching Authority for PCT/US03/08736.
Office Action mailed Dec. 17, 2003, in U.S. Appl. No. 10/393,806.
Office Action mailed Mar. 22, 2004, in U.S. Appl. No. 10/393,806.
Office Action mailed Nov. 16, 2004, in U.S. Appl. No. 10/393,806.
Notice of Allowance and Notice of Allowability and Examiner's Amendment mailed Oct. 18, 2005, in U.S. Appl. No. 10/393,806.
Office Action mailed Dec. 11, 2007, in U.S. Appl. No. 11/332,607.
Office Action mailed Sep. 4, 2008, in U.S. Appl. No. 11/332,607.
Notice of Allowance and Notice of Allowability mailed Apr. 9, 2009, in U.S. Appl. No. 11/332,607.
Supplemental Notice of Allowability and Examiner's Amendment mailed May 1, 2009, in U.S. Appl. No. 11/332,607.
Bhat Laxminarayan
Gallop Mark A.
Xiang Jia-Ning
Yao Fenmei
Chang Lucy S.
Miller D. Byron
Solola Taofiq A
XenoPort, Inc.
LandOfFree
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2698390